1921
Volume 70, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

To assess the magnitude of the Buruli ulcer (BU) problem in Cameroon, we conducted a cross-sectional survey in the Nyong River basin and identified on clinical grounds a total of 436 cases of active or inactive BU (202 and 234, respectively). Swab specimens were taken from 162 active cases with ulcerative lesions and in 135 of these (83.3%) the clinical diagnosis was confirmed by the polymerase chain reaction. Most lesions (93%) were located on the extremities, with lower limbs being twice as commonly involved as upper limbs. The age of patients with active BU ranged from 2 to 90 years with a median age of 14.5 years. Vaccination with bacilli Calmette-Guérin appeared to protect children against more severe forms of BU with multiple lesions. We conclude that in Cameroon BU is endemic, at least in the study area, and that a comprehensive control program for BU in Cameroon is urgently needed.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2004.70.520
2004-05-01
2017-11-21
Loading full text...

Full text loading...

/deliver/fulltext/14761645/70/5/0700520.html?itemId=/content/journals/10.4269/ajtmh.2004.70.520&mimeType=html&fmt=ahah

References

  1. MacCallum P, Tollhurst JC, Buckle G, Sissons HA, 1948. A new mycobacterial infection in man. J Pathol Bacteriol 60 : 93–122.
  2. Clancey JK, Dodge OG, Lunn HF, Oduori ML, 1961. Mycobacterial skin ulcers in Uganda. Lancet 2 : 951–954.
  3. Burchard GD, Bierther M, 1986. Buruli ulcer: clinical pathological study of 23 patients in Lambarene, Gabon. Trop Med Parasitol 37 : 1–8.
  4. Van der Werf TS, van der Graaf WT, 1990. Buruli ulcer in West Africa (letter). Lancet 336 : 1440.
  5. Aguiar J, Domingo M-C, Guédénon A, Meyers W, Steunou C, Portaels F, 1997. L’ulcère de Buruli, une maladie mycobactérienne importante et en recrudescence au Bénin. Bull Seanc Acad Sci Outre Mer 43 : 325–356.
  6. Kanga JM, Kacou ED, 2001. Epidemiological aspects of Buruli ulcer in Côte d’Ivoire: results of a national survey. Bull Soc Pathol Exot 94 : 46–51.
  7. Amofah G, Bonsu F, Tetteh C, Okrah J, Asamoa K, Asiedu K, Addy J, 2002. Buruli ulcer in Ghana: results of a national search. Emerg Infect Dis 8 : 167–170.
  8. World Health Organization, 2001. Buntine J, Crofts K, eds. Buruli Ulcer. Management of Mycobacterium ulcerans Disease. A Manual for Health Care Providers. Geneva: World Health Organization. (WHO/CDS/CPE/GBUI/2001.3).
  9. World Health Organization, 2001. Portaels F, Johnson P, Meyers WM, eds. Buruli Ulcer. Diagnosis of Mycobacterium ulcerans disease. A Manual for Health Care Providers. Geneva: World Health Organization. (WHO/CDS/CPE/GBUI/2001.4).
  10. Meyers WM, Shelly WM, Connor DH, Meyers EK, 1974. Mycobacterium ulcerans infections developing at sites of trauma to skin. Am J Trop Med Hyg 23 : 919–923.
  11. Debacker M, Zinsou C, Aguiar J, Meyers WM, Portaels F, 2003. First case of Mycobacterium ulcerans disease (Buruli ulcer) following a human bite. Clin Infect Dis 36 : e67–e68.
  12. Portaels F, Elsen P, Guimaraes-Peres A, Fonteyne PA, Meyers WM, 1999. Insects in the transmission of Mycobacterium ulcerans infection (Buruli ulcer) (letter). Lancet 353 : 986.
  13. Ravisse P, Roques M-C, Le Bourthe F, Tchuembou CJ, Menard J-J, 1975. Une affection méconnue au Cameroun, l’ulcère à mycobactérie. Med Trop (Mars) 35 : 471–474.
  14. Ravisse P, 1977. L’ulcère à Mycobacterium ulcerans au Cameroun. I. Etude clinique, épidémiologique et histologique. Bull Soc Pathol Exot 70 : 109–124.
  15. Boisvert H, 1977. L’ulcère à Mycobacterium ulcerans au Cameroun. II. Etude bactériologique. Bull Soc Pathol Exot 70 : 125–131.
  16. Ross BC, Marino L, Oppedisano F, Edwards R, Robins-Browne RM, Johnson PD, 1997. Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection. J Clin Microbiol 35 : 1696–1700.
  17. Van der Werf TS, van der Graaf WT, Tappero JW, Asiedu K, 1999. Mycobacterium ulcerans infection. Lancet 354 : 1013–1018.
  18. Marston BJ, Mamadou O, Diallo C, Horsburgh R Jr, Diomande I, Saki MZ, Kanga J-M, G’Bery P, Lipman HB, Ostroff SM, Good RC, 1995. Emergence of Buruli ulcer disease in the Daloa region of Côte d’Ivoire. Am J Trop Med Hyg 52 : 219–224.
  19. Lagarrigue V, Portaels F, Meyers WM, Aguiar J, 2000. L’ulcère de Buruli: attention aux atteintes osseuses! A propos de 33 cas observés au Bénin. Trop Med (Mars) 60 : 262–266.
  20. Uganda Buruli Group, 1969. BCG vaccination against Mycobacterium ulcerans infection (Buruli ulcer). Lancet 1 : 111–115.
  21. Smith PG, Revill WDL, Kukwago E, Rykushin YP, 1976. The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda. Trans R Soc Trop Med Hyg 70 : 449–457.
  22. Portaels F, Aguiar, J, Debacker M, Steunou C, Zinsou C, Guédénon A, Meyers WM, 2002. Prophylactic effect of BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli ulcer). Clin Diagn Lab Immunol 9 : 1389–1391.
  23. Darie H, Le Guyadec T, Touze JE, 1993. Aspects épidémiologiques et cliniques de l’Ulcère de Buruli en Côte d’Ivoire. A propos de 124 observations récentes. Bull Soc Pathol Exot 86 : 272–276.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2004.70.520
Loading
/content/journals/10.4269/ajtmh.2004.70.520
Loading

Data & Media loading...

  • Received : 08 Feb 2003
  • Accepted : 29 May 2003

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error